6 beta-Propynyl-substituted steroids: mechanism-based enzyme-activated irreversible inhibitors of aromatase.
6 beta-Propynyl-substituted steroids: mechanism-based enzyme-activated irreversible inhibitors of aromatase.
复制标题
6 β-丙炔基取代类固醇:基于机制的酶激活不可逆芳香酶抑制剂。
DOI:
10.1021/jm970325z
复制
发表时间:
1997
期刊:
影响因子:
--
通讯作者:
Abul-Hajj,YJ
中科院分区:
文献类型:
--
作者:
Akkani,A;Paterlini,G;Gleason,WB;Ojala,WH;Abul-Hajj,YJ
The synthesis and aromatase inhibitory profile of 6α- and 6β-propargyl androstenedione and estrenedione are described. The targeted compounds1and2were prepared by addition of the propargyl Gringard to the 5α,6α-epoxy bisketal6or the 5α,6α-epoxy diacetate7followed by dehydration of the 6β-propargyl 5α-hydroxy diones10and11using thionyl chloride. Treatment of the 6β-propargyl analogs1and2with hydrochloric acid gave the corresponding 6α-propargyl isomers3and4. Inhibitory activity of the synthesized compounds was assessed using a human placental microsomal preparation as the enzyme source and [1β-3H]-4-androstenedione as substrate. Under initial velocity assay conditions of low product formation, the inhibitors demonstrated potent inhibition of aromatase, with apparentKis ranging from 10 to 66 nM, with theKmfor androstenedione being 55 nM. 6α-Propargylandrost-4-ene-3,17-dione and 6α-propargylestr-4-ene-3,17-dione were found to be potent competitive inhibitors of aromatase (Ki37 and 66 nM, respectively). On the other hand the 6β-propargylandrost-4-ene-3,17-dione (6β-PAD) and 6β-propargylestr-4-ene-3,17-dione (6β-PED) were found to bind to aromatase with an apparentKiof 10 and 48 nM, respectively, as well as cause rapid time-dependent, first-order inactivation of aromatase in the presence of NADPH, whereas no inactivation was observed in the absence of NADPH. Substrate protects the enzyme from inactivation, but β-mercaptoethanol does not, suggesting that the 6β-propargyl analogs 6β-PAD and 6β-PED are mechanism-based inactivators of aromatase. Energy-minimization calculations and molecular modeling studies indicate three global minima for each of the 6β-propargyl analogs in which one of the conformers is proposed to be responsible for the inactivation of aromatase.